Talon Capital Corp. Files 8-K with Material Agreements & Equity Sales

TL;DR

Talon Capital Corp. dropped an 8-K detailing new deals, stock sales, and exec changes. Watch this space.

AI Summary

Talon Capital Corp. filed an 8-K on September 12, 2025, reporting several key events as of September 8, 2025. These include entering into a material definitive agreement, unregistered sales of equity securities, and changes related to directors and officers, including compensatory arrangements. The company also amended its articles of incorporation or bylaws and reported other events and financial statements/exhibits.

Why It Matters

This filing indicates significant corporate actions by Talon Capital Corp., including potential new financing or strategic partnerships and changes in its leadership structure, which could impact its future operations and stock performance.

Risk Assessment

Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.

Key Numbers

• 11.50 — Exercise Price (Warrants are exercisable for one Class Ordinary Share at this price.)

Key Players & Entities

• Talon Capital Corp. (company) — Filer of the 8-K
• 0002073340 (company) — Central Index Key for Talon Capital Corp.
• TLNCU (company) — Ticker symbol for Talon Capital Corp. units

FAQ

Key Financial Figures

• $0.0001 — LC Class A ordinary shares, par value $0.0001 per share TLNC The Nasdaq Stock Mar
• $11.50 — ordinary share at an exercise price of $11.50 TLNCW The Nasdaq Stock Market LLC
• $10.00 — Units were sold at an offering price of $10.00 per Unit, generating gross proceeds to
• $249,000,000 — rating gross proceeds to the Company of $249,000,000. In connection with the Offering, the
• $7,790,000 — ment Unit, generating gross proceeds of $7,790,000 (the "Private Placement"). No underwrit
• $500,000 — ts, which amount shall be the lesser of $500,000 or 5% of the interest earned on the Tru

Filing Documents

• ea0256900-8k_talon.htm (8-K) — 55KB
• ea025690003ex1-1_talon.htm (EX-1.1) — 279KB
• ea025690003ex3-1_talon.htm (EX-3.1) — 290KB
• ea025690003ex4-1_talon.htm (EX-4.1) — 98KB
• ea025690003ex10-1_talon.htm (EX-10.1) — 43KB
• ea025690003ex10-2_talon.htm (EX-10.2) — 81KB
• ea025690003ex10-3_talon.htm (EX-10.3) — 107KB
• ea025690003ex10-4_talon.htm (EX-10.4) — 66KB
• ea025690003ex10-5_talon.htm (EX-10.5) — 60KB
• ea025690003ex10-6_talon.htm (EX-10.6) — 11KB
• ea025690003ex99-1_talon.htm (EX-99.1) — 6KB
• ea025690003ex99-2_talon.htm (EX-99.2) — 6KB
• 0001213900-25-087276.txt ( ) — 1575KB
• tlncu-20250908.xsd (EX-101.SCH) — 4KB
• tlncu-20250908_def.xml (EX-101.DEF) — 27KB
• tlncu-20250908_lab.xml (EX-101.LAB) — 37KB
• tlncu-20250908_pre.xml (EX-101.PRE) — 25KB
• ea0256900-8k_talon_htm.xml (XML) — 7KB

01. Entry into a Material Definitive Agreement

Item 1.01. Entry into a Material Definitive Agreement. On September 8, 2025, the registration statement on Form S-1 (File No. 333-289674) (the "Registration Statement") relating to the initial public offering (the "Offering") of Talon Capital Corp., a Cayman Islands exempted company (the "Company"), was declared effective by the U.S. Securities and Exchange Commission. On September 10, 2025, the Company consummated the Offering of 24,900,000 units (the "Units"), including 2,400,000 Units issued pursuant to the underwriters' partial exercise of the over-allotment. Each Unit consists of one Class A ordinary share, par value $0.0001 per share ("Class A Ordinary Shares"), and one-third of one redeemable warrant (each, a "Warrant"), each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share at an exercise price of $11.50 per share, subject to adjustment. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds to the Company of $249,000,000. In connection with the Offering, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Registration Statement: An Underwriting Agreement, dated September 8, 2025, between the Company and Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC, as representative of the underwriters named therein (the "Representative"), a copy of which is filed as Exhibit 1.1 to this Current Report on Form 8-K (this "Report") and incorporated herein by reference; A Warrant Agreement, dated September 8, 2025, between the Company and Odyssey Transfer and Trust Company ("Odyssey"), as warrant agent, a copy of which is filed as Exhibit 4.1 to this Report and incorporated herein by reference; An Insider Letter Agreement, dated September 8, 2025, among the Company, its directors and officers and Talon Capital Sponsor LLC (the "Sponsor"), a copy of which is filed as Exhibit 10.1 to this Report and incorporated herein

02. Unregistered Sales of Equity Securities

Item 3.02. Unregistered Sales of Equity Securities. On September 10, 2025, simultaneously with the consummation of the Offering, the Company consummated the private placement of 530,000 units to the Sponsor and 249,000 units to the Representative (collectively, the "Private Placement Units") at a price of $10.00 per Private Placement Unit, generating gross proceeds of $7,790,000 (the "Private Placement"). No underwriting discounts or commissions were paid with respect to the Private Placement. The Private Placement was conducted as a non-public transaction and, as a transaction by an issuer not involving a public offering, is exempt from registration under the Securities Act in reliance upon Section 4(a)(2) of the Securities Act. The Private Placement Units are identical to the Units, except that so long as they are held by the initial purchasers or their permitted transferees, they (i) may not (including the underlying securities), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the Company's initial business combination, (ii) are entitled to registration rights and (iii) with respect to Private Placement Units held by the Representative and/or their designees, will not be exercisable more than five years from the commencement of sales in the Offering in accordance with FINRA Rule 5110(g)(8).

02. Departure of Directors or Certain

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective as of September 8, 2025, the following individuals were appointed to the board of directors of the Company: Shawn Reynolds and Thomas Simons. Accordingly, effective as of September 8, 2025, the Company's board of directors is comprised of the following individuals: Charles Leykum, Shawn Reynolds and Thomas Simons. Additional information regarding, among other things, each individual's background, board committee membership and compensatory arrangements is contained in the Registration Statement and is incorporated herein by reference. On September 8, 2025, the Company entered into the Indemnity Agreements with each of Charles Leykum, Gerald Cimador, Shawn Reynolds and Thomas Simons, which require the Company to indemnify each of them to the fullest extent permitted by applicable law and to advance expenses incurred as a result of any proceeding against them as to which they could be indemnified. The foregoing description of the Indemnity Agreements is qualified in its entirety by reference to the full text of the form of Indemnity Agreement filed as Exhibit 10.7 to this Report, which is incorporated herein by reference.

03. Amendments to Articles of Incorporation

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On September 8, 2025, the Company filed its amended and restated memorandum and articles of association (the "Amended Articles") with the Registrar of Companies in the Cayman Islands. Among other things, the Amended Articles authorize the issuance of up to (i) 200,000,000 Class A Ordinary Shares, (ii) 20,000,000 Class B ordinary shares, par value $0.0001 per share, and (iii) 1,000,000 preference shares, par value $0.0001 per share. The terms of the Amended Articles are set forth in the Registration Statement and are incorporated herein by reference. The foregoing description of the Amended Articles is qualified in its entirety by reference to the full text of the Amended Articles, a copy of which is filed as Exhibit 3.1 to this Report and incorporated herein by reference.

01. Other Events

Item 8.01. Other Events. A total of $249,000,000 ($10.00 per Unit) of the net proceeds from the Offering and the Private Placement was placed in a trust account established for the benefit of the Company's public shareholders (the "Trust Account"), with Odyssey acting as trustee. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to fund the Company's working capital requirements, which amount shall be the lesser of $500,000 or 5% of the interest earned on the Trust Account per annum, and/or to pay the Company's taxes, other than excise taxes, if any, provided that all such permitted withdrawals can only be made (x) from interest and not from the principal held in the Trust Account and (y) only to the extent such interest is in amount sufficient to cover the permitted withdrawal amount, and the funds held in the Trust Account will not be released from the Trust Account until the earliest of: (i) the completion of the Company's initial business combination, (ii) the redemption of the Class A Ordinary Shares underlying the Units (the "Public Shares") if the Company is unable to complete its initial business combination by September 10, 2027, or such earlier date as the Company's board of directors may approve, or such other time period in which the Company must complete an initial business combination pursuant to an amendment to the Amended Articles approved by a special resolution of the Company's shareholders (collectively, the "Completion Window"), subject to applicable law, or (iii) the redemption of the Public Shares properly submitted in connection with a shareholder vote to amend the Amended Articles (a) to modify the substance or timing of the Company's obligation to allow redemption in connection with its initial business combination or to redeem 100% of the Public Shares if the Company has not consummated an initial business combination within the Completion Window or (b) with respect to any ot

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 1.1 Underwriting Agreement, dated September 8, 2025, between the Company and Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC. 3.1 Amended and Restated Memorandum and Articles of Association of the Company. 4.1 Warrant Agreement, dated September 8, 2025, between the Company and Odyssey Transfer and Trust Company. 10.1 Insider Letter Agreement, dated September 8, 2025, among the Company, its directors and officers and Talon Capital Sponsor LLC. 10.2 Investment Management Trust Agreement, dated September 8, 2025, between the Company and Odyssey Transfer and Trust Company. 10.3 Registration Rights Agreement, dated September 8, 2025, among the Company and certain security holders. 10.4 Private Placement Units Purchase Agreement, dated September 8, 2025, between the Company and Talon Capital Sponsor LLC. 10.5 Private Placement Units Purchase Agreement, dated September 8, 2025, between the Company and Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC. 10.6 Administrative Services Agreement, dated September 8, 2025, between the Company and Talon Capital Sponsor LLC. 10.7 Form of Indemnity Agreement (incorporated by reference to an exhibit to the Registrant's Form S-1 (File No. 333-289674), filed with the SEC on August 15, 2025). 99.1 Press Release, dated September 8, 2025. 99.2 Press Release, dated September 10, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 3 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. talon capital corp. By: /s/ Charles Leykum Name: Charles Leykum Title: Chief Executive Officer Date: September 12, 2025 4

View Full Filing

View this 8-K filing on SEC EDGAR